Draper has announced a significant advancement in health care technology that could help transform the diagnosis and treatment of mental health conditions, such as post-traumatic stress disorder (PTSD) and depression.
CAMBRIDGE, Mass., Oct. 16, 2024 /PRNewswire-PRWeb/ -- Draper has announced a significant advancement in health care technology that could help transform the diagnosis and treatment of mental health conditions, such as post-traumatic stress disorder (PTSD) and depression.
Led by Andrea Webb, Ph.D., Draper's latest innovation combines advanced sensors, advanced analytics and machine learning to provide a more accurate and comprehensive view of a patient's mental health.
Draper's approach is designed to enable earlier and better detection of mental health issues, more personalized treatment plans and improved monitoring of patient progress, ultimately enhancing outcomes and quality of life. Such technology approaches come with important considerations around ethics, equity and equality, which Dr. Webb and her team are actively exploring.
This new approach aims to address challenges with traditional methods, like self-reporting, which can often be unreliable. Instead, Draper's technology continuously collects real-time data from various physiometric indicators, including heart rate, skin responses and eye movements, offering health care providers a dynamic and detailed understanding of an individual's condition.
This technology approach marks a significant step forward in mental health care, with the potential to make impactful changes in how these conditions are managed.
"Post-traumatic stress disorder and major depressive disorder (MDD) are two recognized mental health conditions that can affect warfighters and civilians in significant ways," Webb said. "Our goal is to augment and improve the diagnosis and treatment of these types of conditions."
Dr. Webb recently presented her work at the 2024 Home Base Brain Health Summit, held on Sept. 11-12, 2024, at the MGH Institute of Health Professions in Boston.
Dr. Webb is Chief Scientist of Human Centered Solutions at Draper. She has studied physiometric responses in individuals with PTSD and MDD to identify specific indicators that could be used to better diagnose individuals, as well as to better monitor therapeutic responses. For example, her work has quantified differences in cardiac and electrodermal responses to various types of emotionally evocative stimuli among those with PTSD and MDD versus those without.
For more information on Draper's new technology and its potential implications, visit Draper's website.
Draper
As a nonprofit engineering innovation company, Draper serves the nation's interests and security needs; advances technologies at the intersection of government, academia and industry; cultivates the next generation of innovators; and solves the most complex challenges. Multidisciplinary teams drawn from a broad and deep talent pool of 1,800 engineers and scientists collaborate to develop first-of-a-kind solutions. Draper's unbiased approach enables the company to focus on their customers' needs and to deliver new capabilities to them. Learn more at draper.com.
Media Contact
Scott Deitz, Draper, 1 336-908-7759, [email protected], Draper.com
SOURCE Draper
Share this article